Atropine Sulfate Injection
Atropine Sulfate Injection is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Atropine Sulfate. Available dosage form: injection, solution. The FDA currently lists a drug shortage record for this product with status Current.
Drug Details
- Generic Name
- Atropine Sulfate Injection
- Brand Names
- Atropine Sulfate
- Application Number
- ANDA214970
- Sponsor
- ProPharma Distribution
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- ATROPINE SULFATE
Shortage Status
Current
Indications and Usage
1 INDICATIONS AND USAGE Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960